DoW Reconstructive Transplant, Concept Award
This grant funds innovative, early-stage research ideas in reconstructive transplantation for FY26, excluding clinical trials and preliminary data, and encourages early-career investigators to apply.
Funder: Dept. of the Army -- USAMRAA
Due Dates: October 21, 2026 (Pre-Application/LOI) | November 4, 2026 (Full Application) | November 9, 2026 (End of Verification)
Funding Amounts: ~$600,000 total; up to $200,000 per award for up to 18 months; ~3 awards expected
Summary: Supports highly innovative, early-stage research on reconstructive transplantation, excluding clinical trials, with emphasis on new concepts or untested theories.
Key Information: Preliminary data are not allowed; early-career investigators are encouraged; clinical trials are not permitted.
Description
This opportunity, managed by the Defense Health Agency Contracting Activity (DHACA) and administered by the U.S. Army Medical Research Acquisition Activity (USAMRAA), funds the exploration of innovative, high-risk concepts in reconstructive transplantation. The Concept Award mechanism specifically targets new ideas, paradigms, or untested theories that address critical gaps in vascularized composite allotransplantation (VCA), such as hand or face transplants. Projects must align with at least one of the focus areas outlined for FY26, and are intended to provide a foundation for future, more developed research efforts.
Clinical trials are not supported under this mechanism. The program encourages applications from early-career investigators and prohibits the inclusion of preliminary data, although a strong rationale and demonstration of feasibility are required.
